Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Other Non-Current Liabilities (2024 - 2025)

Eton Pharmaceuticals' Other Non-Current Liabilities history spans 2 years, with the latest figure at $3.9 million for Q3 2025.

  • For Q3 2025, Other Non-Current Liabilities changed N/A year-over-year to $3.9 million; the TTM value through Sep 2025 reached $3.9 million, changed N/A, while the annual FY2024 figure was $1.8 million, N/A changed from the prior year.
  • Other Non-Current Liabilities for Q3 2025 was $3.9 million at Eton Pharmaceuticals, down from $4.3 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $4.3 million in Q2 2025 and bottomed at $1.8 million in Q4 2024.